UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002666
Receipt number R000003246
Scientific Title Efficacy of topical unoprostone treatment for nonarteritic anterior ischemic optic neuropathy
Date of disclosure of the study information 2009/12/01
Last modified on 2019/05/08 12:04:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of topical unoprostone treatment for nonarteritic anterior ischemic optic neuropathy

Acronym

Topical unoprostone treatment for nonarteritic anterior ischemic optic neuropathy

Scientific Title

Efficacy of topical unoprostone treatment for nonarteritic anterior ischemic optic neuropathy

Scientific Title:Acronym

Topical unoprostone treatment for nonarteritic anterior ischemic optic neuropathy

Region

Japan


Condition

Condition

Nonarteritic anterior ischemic optic neuropathy

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Efficacy of unoprostone treatment for nonarteritic anterior ischemic optic neuropathy

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase III


Assessment

Primary outcomes

Mean deviation of Humphrey field analyzer at 12 months

Key secondary outcomes

Mean deviation of Humphrey field analyzer at 6 months
Visual acuity at 6, 12 months
Goldmann perimetry at 12 months
Ocular fundus at 6, 12 months
Retinal nerve fiber layer thickness using optical coherence tomography at 6, 12 months


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is considered as a block.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Unoprostone
3 drops twice a day for the first month
2 drops twice a day after the first month until 1 year

Interventions/Control_2

Control (Vitamine B12)
3 drops twice a day for the first month
2 drops twice a day after the first month until 1 year

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Aged 50 years or older
2) Duration of symptoms < 2 weeks
3) Visual loss or visual field defects consistent with optic neuropathy
4) Painless
5) Relative afferent pupillary defect
6) Optic disc edema

Key exclusion criteria

Arteritic ischemic optic neuropathy
Glaucoma
Optic neuritis
Compressive optic neuropathy
Leber hereditary optic neuropathy
Toxic and nutritional optic neuropathy

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Keigo
Middle name
Last name Shikishima

Organization

The Jikei University School of Medicine

Division name

Department of Ophthalmology

Zip code

105-8461

Address

3-25-8, Nishi-shinbashi, Minato-ku

TEL

03-3433-1111

Email

shiki@jikei.ac.jp


Public contact

Name of contact person

1st name Keigo
Middle name
Last name Shikishima

Organization

The Jikei University School of Medicine

Division name

Department of Ophthalmology

Zip code

105-8461

Address

3-25-8, Nishi-shinbashi, Minato-ku

TEL

03-3433-1111

Homepage URL


Email

shiki@jikei.ac.jp


Sponsor or person

Institute

The Jikei University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

The Jikei University School of Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Jikei University School of Medicine

Address

3-25-8, Nishi-shinbashi, Minato-ku Tokyo, 105-8461, Japan

Tel

03-3433-1111

Email

rinri@jikei.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京慈恵会医科大学附属病院(東京都),井上眼科病院(東京都),杏林大学医学部附属病院(東京都),鴨下眼科クリニック(東京都),清澤眼科医院(東京都),日本大学医学部附属板橋病院(東京都)


Other administrative information

Date of disclosure of the study information

2009 Year 12 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 10 Month 16 Day

Date of IRB

2009 Year 10 Month 16 Day

Anticipated trial start date

2009 Year 12 Month 01 Day

Last follow-up date

2016 Year 10 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2009 Year 10 Month 25 Day

Last modified on

2019 Year 05 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003246


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name